Clinical Trial Update: Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters [Phase 4]

View source ↗

Summary

Clinical trial update for Optilume PoST evaluating andrology parameters in urethral stricture; Phase 4 study currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urethral Stricture

Drugs mentioned

• Optilume PoST (paclitaxel-coated balloon catheter)

Snippet

Sponsor: Urotronic Inc. | Conditions: Urethral Stricture | Phase 4 | Status: RECRUITING